Tae Jung Kim

3.9k total citations
184 papers, 2.5k citations indexed

About

Tae Jung Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tae Jung Kim has authored 184 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 38 papers in Surgery. Recurrent topics in Tae Jung Kim's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Lung Cancer Research Studies (16 papers). Tae Jung Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Lung Cancer Research Studies (16 papers). Tae Jung Kim collaborates with scholars based in South Korea, United States and Australia. Tae Jung Kim's co-authors include Jin-Haeng Chung, Kyo Young Lee, Young Kyoon Kim, Chan Kwon Park, Young Hoon Kim, Seung Joon Kim, Kyung Won Lee, Chang Suk Kang, Chang Dong Yeo and Youn Soo Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tae Jung Kim

168 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tae Jung Kim South Korea 28 990 569 568 397 309 184 2.5k
Chenyang Dai China 26 1.3k 1.3× 345 0.6× 360 0.6× 588 1.5× 195 0.6× 112 2.3k
Haresh Mani United States 25 1.4k 1.4× 358 0.6× 526 0.9× 764 1.9× 156 0.5× 67 3.2k
Luc Thiberville France 26 1.3k 1.3× 502 0.9× 394 0.7× 310 0.8× 265 0.9× 111 2.5k
Kyo Young Lee South Korea 31 1.3k 1.3× 748 1.3× 759 1.3× 309 0.8× 339 1.1× 181 3.0k
Go Kimura Japan 25 1.0k 1.0× 550 1.0× 573 1.0× 258 0.6× 285 0.9× 167 2.4k
Jian Hu China 27 1.1k 1.1× 588 1.0× 649 1.1× 307 0.8× 308 1.0× 201 2.4k
Dong Kwan Kim South Korea 26 1.2k 1.3× 707 1.2× 584 1.0× 190 0.5× 290 0.9× 168 2.8k
Yosuke Sasaki Japan 28 465 0.5× 1.0k 1.8× 532 0.9× 233 0.6× 172 0.6× 167 2.5k
Atsushi Arakawa Japan 27 696 0.7× 830 1.5× 683 1.2× 157 0.4× 461 1.5× 179 2.7k

Countries citing papers authored by Tae Jung Kim

Since Specialization
Citations

This map shows the geographic impact of Tae Jung Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae Jung Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae Jung Kim more than expected).

Fields of papers citing papers by Tae Jung Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tae Jung Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae Jung Kim. The network helps show where Tae Jung Kim may publish in the future.

Co-authorship network of co-authors of Tae Jung Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Tae Jung Kim. A scholar is included among the top collaborators of Tae Jung Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae Jung Kim. Tae Jung Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Mingyu, et al.. (2025). Optimizing Cancer Treatment Through Gut Microbiome Modulation. Cancers. 17(7). 1252–1252. 7 indexed citations
2.
Kim, Tae Jung, et al.. (2025). Advancements in Uricase formulations: overcoming therapeutic challenges in enzyme replacement therapy. Journal of Pharmaceutical Investigation. 55(4). 521–556. 1 indexed citations
3.
Lee, Mingyu, et al.. (2025). Advancements in Electronic Medical Records for Clinical Trials: Enhancing Data Management and Research Efficiency. Cancers. 17(9). 1552–1552. 2 indexed citations
5.
Lee, Mingyu, et al.. (2025). Spatial Omics in Clinical Research: A Comprehensive Review of Technologies and Guidelines for Applications. International Journal of Molecular Sciences. 26(9). 3949–3949. 7 indexed citations
6.
Kim, Tae Jung, Eun Ji Han, Gi June Min, et al.. (2024). Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma. Cancer Medicine. 14(1). e70565–e70565.
7.
Kim, Yerim, Byung‐Woo Yoon, Sang‐Hwa Lee, et al.. (2023). U-shaped associations between glycated albumin and obesity and role of IL-10 in hyperacute ischemic stroke. Clinical Neurology and Neurosurgery. 233. 107915–107915.
8.
Cho, Uiju, Tae Jung Kim, Wan Seop Kim, et al.. (2023). Current state of cytopathology residency training: a Korean national survey of pathologists. Journal of Pathology and Translational Medicine. 57(2). 95–101. 1 indexed citations
9.
Kim, Taeeun, Taeeun Kim, Chan Kwon Park, et al.. (2022). Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression in Non-Small-Cell Lung Cancer Using Routine Clinical and Conditioned Archives. Cancers. 14(13). 3138–3138. 8 indexed citations
10.
Cho, Uiju, et al.. (2022). Prognostic Implication of Exfoliative Airway Pathology in Cancer-Free Coal Workers’ Pneumoconiosis. International Journal of Environmental Research and Public Health. 19(22). 14975–14975. 1 indexed citations
11.
Kang, Nae‐Won, Dong Hwan Lee, Ji Hoon Yoo, et al.. (2022). Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate‐decorated albumin nanoclusters in osteosarcoma treatment. Bioengineering & Translational Medicine. 8(6). e10472–e10472. 5 indexed citations
12.
Ahn, Hyo–Suk, Dong Hyeon Lee, Tae Jung Kim, Hyeon‐Cheol Shin, & Hui‐Kyung Jeon. (2017). Cardioprotective Effects of a Phlorotannin Extract Against Doxorubicin-Induced Cardiotoxicity in a Rat Model. Journal of Medicinal Food. 20(10). 944–950. 6 indexed citations
13.
Lim, Jeong Uk, Chang Dong Yeo, Chin Kook Rhee, et al.. (2015). Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations. PLoS ONE. 10(11). e0142306–e0142306. 27 indexed citations
14.
Han, Ji Won, et al.. (2015). Molecular Characterization of β-Lactamase-Producing Escherichia coli Collected from 2001 to 2011 from Pigs in Korea. Foodborne Pathogens and Disease. 13(2). 68–76. 6 indexed citations
15.
Hong, Ji Hyung, Ji Young Kang, Tae Jung Kim, et al.. (2011). A Case of Bronchiolitis Obliterans Organizing Pneumonia after Radiation Therapy in Breast Cancer. The Korean Journal of Internal Medicine. 80(4). 458–463.
16.
Kim, Ju‐Hyoung, et al.. (2011). A new rose cultivar 'Suryeo' with white-pink flower color.. Horticultural Science and Technology. 29(2). 160–163. 1 indexed citations
17.
Kim, Tae Jung, et al.. (2010). Prognostic significance of expression of vegf and cox‐2 in nasopharyngeal carcinoma and its association with expression of C‐erbB2 and EGFR. Journal of Surgical Oncology. 103(1). 46–52. 30 indexed citations
18.
Kim, Jin Woo, Chin Kook Rhee, Tae Jung Kim, et al.. (2010). Effect of pravastatin on bleomycin‐induced acute lung injury and pulmonary fibrosis. Clinical and Experimental Pharmacology and Physiology. 37(11). 1055–1063. 42 indexed citations
19.
Kim, Tae Jung, Eun Sun Jung, Hyeon Woo Yim, et al.. (2009). The Comparison of Automated Silver in situ Hybridization and Fluorescence in situ Hybridization for Evaluating HER2 Gene Amplification in Breast Carcinoma. Journal of Breast Cancer. 12(4). 295–295. 6 indexed citations
20.
Choi, Suk Jin, et al.. (2005). Clinical and histopathological studies on ovarian tumors. Obstetrics & Gynecology Science. 48(4). 919–928. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026